Libifem® (Fenugreek for Female Libido — Saanroo)

Trigonella foenum-graecum
Evidence Level
Limited
3 Clinical Trials
5 Documented Benefits
2/5 Evidence Score

Libifem® is a fenugreek (Trigonella foenum-graecum) seed extract standardized to 50% furostanol saponins. It is sold by Saanroo, the nutraceutical company formerly called Gencor, and is marketed for female sexual desire, menopause comfort and strength training. Its libido evidence is one double-blind, placebo-controlled trial in 80 healthy menstruating women aged 20 to 49 who reported low sexual drive: 600 mg a day for two menstrual cycles improved sexual desire and arousal and raised free testosterone and estradiol compared with placebo. Separate placebo-controlled trials looked at menopausal symptoms and at strength training. The three trials share authors, the exercise trial was funded by the supplier, and no independent team has repeated them. Fenugreek studies in men, including those on Testofen®, are not evidence for Libifem in women.

Studied Dose 600 mg a day in all three published trials, split into two doses in the exercise trial. A 300 mg dose was tested only in the exercise trial and did not change fat mass or lean mass more than placebo.
Active Compound Furostanol saponins from fenugreek seed; Libifem is standardized to 50% furostanol saponins.

Benefits

Female sexual desire and arousal

In a double-blind, placebo-controlled trial, 80 healthy menstruating women aged 20 to 49 who reported low sexual drive took 600 mg a day or placebo for two menstrual cycles, about 8 weeks. Sexual desire and arousal improved more than with placebo. This is one trial of 80 women; its lead author also led the supplier-funded Libifem exercise trial, and no independent group has repeated it.

Hot flushes and night sweats around menopause

In a 12-week double-blind trial of 115 healthy women aged 40 to 65, 600 mg a day reduced daytime hot flushes and night sweats and improved menopause-related quality of life scores, including the sexual symptoms section, more than placebo. Estradiol levels ended up similar in both groups. The abstract names a proprietary de-husked fenugreek extract rather than Libifem by name.

Leg strength and lean mass with resistance training

In an 8-week placebo-controlled trial, women aged 25 to 45 all followed the same whole-body exercise program three times a week. The 600 mg a day group gained more leg-press strength and lean mass and lost more fat than placebo, while 300 mg a day did not change fat mass. Testosterone did not change in any group, and the supplier funded the trial.

Free testosterone and estradiol levels

In the 80-woman libido trial, 600 mg a day raised free testosterone and estradiol compared with placebo. In the later exercise trial, testosterone did not change in any group. The libido trial also measured SHBG, the protein that binds sex hormones, but its abstract reports changes only for free testosterone and estradiol, so how the extract works is not established.

Tolerability in trials

Mild digestive discomfort is the most commonly reported side effect of fenugreek in general. In the Libifem exercise trial, 7 of 129 enrolled women withdrew because of adverse events: 5 on Libifem (bloating, knee pain, acne and reflux) and 2 on placebo, including the one serious event, a bowel obstruction. Trials lasted 8 to 12 weeks, so longer-term safety is unknown.

Mechanism of action

1

Proposed hormone effects

The authors of the exercise trial suggest fenugreek may free more testosterone and estradiol from the proteins that carry them in the blood. The 80-woman trial did find higher free testosterone and estradiol after 600 mg a day, but this pathway has not been shown directly in people.

2

Possible Effects on Strength and Body Composition

The strength and body composition results in women come from one Libifem trial at 600 mg a day alongside a supervised exercise program, not from studies of other fenugreek brands in men. How the extract produces those changes has not been established.

3

Standardized saponin content

Libifem is standardized to 50% furostanol saponins, which helps keep batches consistent. Other fenugreek extracts use different standardizations, so results from one brand should not be assumed for another.

Clinical trials

1
Libifem for Female Sexual Function
PubMed

Single-site, double-blind, randomized, placebo-controlled trial of 600 mg a day for two menstrual cycles, about 8 weeks. Hormones, sexual function questionnaires, stress, fatigue and relationship quality were measured (Rao et al. 2015, Phytotherapy Research).

80 healthy menstruating women aged 20 to 49 who reported low sexual drive.

Sexual desire and arousal improved more than with placebo, and free testosterone and estradiol rose. The abstract does not report results for stress, fatigue or relationship quality. This single trial has not been repeated by an independent group.

2
Libifem with Resistance Training in Women
PubMed

Randomized, placebo-controlled trial of 300 mg or 600 mg a day for 8 weeks. Everyone, including the placebo group, followed the same whole-body exercise program three times a week. Funded by Gencor Pacific (Rao et al. 2023, Frontiers in Sports and Active Living).

Women aged 25 to 45; 129 enrolled and 74 completed all requirements.

Only the 600 mg group improved leg-press strength more than placebo; it also lost about 0.96 kg of fat versus a 0.09 kg gain on placebo and gained more lean mass than the 300 mg and placebo groups. Testosterone did not change in any group. Seven women withdrew because of adverse events.

3
Fenugreek Seed Extract for Menopausal Symptoms
PubMed

Double-blind, randomized, placebo-controlled trial of a proprietary de-husked fenugreek seed extract, 600 mg a day for 12 weeks (Steels et al. 2017, Phytotherapy Research).

115 healthy women aged 40 to 65; 104 completed.

Total menopause-specific quality of life scores improved more than placebo, including the vasomotor, psychosocial, physical and sexual sections, and daytime hot flushes and night sweats fell. Average estradiol levels were similar in both groups after treatment.

Side effects and drug interactions

Common Potential side effects

Mild digestive discomfort is the most commonly reported side effect of fenugreek.
Fenugreek can cause a maple-syrup-like smell in urine and sweat.
Large doses of fenugreek may cause a harmful drop in blood sugar.
Allergic reactions, including serious ones, have been reported; cross-reaction with chickpeas, peanuts and other legumes is possible.
Fenugreek is not considered safe in pregnancy in amounts greater than those found in food.
Libifem trials lasted 8 to 12 weeks, so longer-term safety is unknown.

Important Drug interactions

Diabetes medicines: fenugreek may add to their blood-sugar-lowering effect.
Warfarin: fenugreek has been reported to interact with warfarin and cause bleeding, so INR may need closer checks.
Hormonal contraceptives or hormone therapy: Libifem raised free testosterone and estradiol in one trial, so ask your doctor before combining them.
Any prescription medicine: talk with your health care provider before using fenugreek products.

Frequently asked questions about Libifem® (Fenugreek for Female Libido — Saanroo)

What is Libifem?

Libifem® is a fenugreek (Trigonella foenum-graecum) seed extract standardized to 50% furostanol saponins. It is sold by Saanroo, the nutraceutical company formerly called Gencor, and is marketed for female sexual desire, menopause comfort and strength training.

What is Libifem used for?

Libifem is researched primarily for Women's Health and Libido Support. In a double-blind, placebo-controlled trial, 80 healthy menstruating women aged 20 to 49 who reported low sexual drive took 600 mg a day or placebo for two menstrual cycles, about 8 weeks.

What is the recommended dosage of Libifem?

The clinically studied dose is 600 mg a day in all three published trials, split into two doses in the exercise trial. A 300 mg dose was tested only in the exercise trial and did not change fat mass or lean mass more than placebo. Always follow the product label and check with a healthcare provider for personal advice.

Is Libifem safe, and does it have side effects?

Side effects and cautions reported for Libifem include: Mild digestive discomfort is the most commonly reported side effect of fenugreek. Fenugreek can cause a maple-syrup-like smell in urine and sweat. It may also interact with some medications. Libifem is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does Libifem interact with any medications?

Possible interactions include: Diabetes medicines: fenugreek may add to their blood-sugar-lowering effect. Warfarin: fenugreek has been reported to interact with warfarin and cause bleeding, so INR may need closer checks. If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for Libifem?

NutraSmarts rates the evidence for Libifem as Limited (2 out of 5). It is backed by 3 study summaries and 6 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(6 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Steels E, Steele ML, Harold M, Coulson S. Efficacy of a Proprietary Trigonella foenum-graecum L. De-Husked Seed Extract in Reducing Menopausal Symptoms in Otherwise Healthy Women: A Double-Blind, Randomized, Placebo-Controlled Study. Phytother Res. 2017;31(9):1316-1322. doi: 10.1002/ptr.5856.PubMedUsed to support: Double-blind, randomized, placebo-controlled trial in 115 healthy women aged 40 to 65: a proprietary de-husked fenugreek seed extract, 600 mg a day for 12 weeks, reduced daytime hot flushes and night sweats and improved menopause-specific quality of life scores, including the sexual symptoms section, versus placebo. Estradiol did not differ between groups. The abstract does not name Libifem; the supplier markets this trial as Libifem evidence. It shares an author with the 2015 Libifem libido trial.
  2. Rao A, Clayton P, Briskey D. Libifem® (Trigonella foenum-graecum) in conjunction with exercise on muscle strength, power, endurance, and body composition in females aged between 25 and 45 years. Front Sports Act Living. 2023;5:1207013. doi: 10.3389/fspor.2023.1207013.PubMedUsed to support: Randomized, placebo-controlled 8-week trial of Libifem 300 or 600 mg a day in women aged 25 to 45 following the same exercise program. Only 600 mg improved leg-press strength versus placebo and reduced fat mass, with more lean mass gain than 300 mg or placebo. Testosterone did not change. Funded by Gencor Pacific; 74 of 129 enrolled women completed. Libido was not measured.
  3. Rao A, Steels E, Beccaria G, Inder WJ, Vitetta L. Influence of a Specialized Trigonella foenum-graecum Seed Extract (Libifem), on Testosterone, Estradiol and Sexual Function in Healthy Menstruating Women, a Randomised Placebo Controlled Study. Phytother Res. 2015;29(8):1123-30. doi: 10.1002/ptr.5355.PubMedUsed to support: Single-site, double-blind, randomized, placebo-controlled trial: 80 healthy menstruating women aged 20 to 49 with low sexual drive took Libifem 600 mg a day or placebo for two menstrual cycles. Sexual desire and arousal improved and free testosterone and estradiol rose versus placebo. SHBG, stress, fatigue and relationship quality were also measured, but the abstract does not report results for them.
  4. Amiri Ardekani E, Parvizi MM, Zare R, Mosaffa Jahromi M, Rampp T, Pasalar M. Exploring the Adverse Effects of Fenugreek in Humans: A Scoping Review. Iran J Med Sci. 2026;51(1):4-18. doi: 10.30476/ijms.2025.106073.4017.PubMedUsed to support: Scoping review of 60 articles on fenugreek adverse effects in humans: mild digestive discomfort was most common; hypoglycemia, possible low potassium, allergic reactions, maple-syrup odor of urine, sweat or skin, and some drug interactions were also reported. No deaths have been attributed to fenugreek.
  5. Drugs and Lactation Database (LactMed), National Institute of Child Health and Human Development. Fenugreek. Drugs and Lactation Database (LactMed). 2006;Bethesda (MD): National Institute of Child Health and Human Development; 2006-. Updated 2026 Jul 15..PubMedUsed to support: NIH LactMed fenugreek monograph: notes possible cross-reaction with chickpeas, peanuts and other legumes, digestive side effects, and that fenugreek can interact with warfarin to cause bleeding.
  6. National Center for Complementary and Integrative Health. Fenugreek. NCCIH (National Institutes of Health). ;Web page..SourceUsed to support: NIH NCCIH fenugreek fact sheet (not PubMed-indexed): fenugreek can cause allergic reactions, large doses may cause a harmful drop in blood sugar, and it is not safe in pregnancy in amounts greater than those found in food.